EMED · Electromedical Technologies, Inc
$0.00
+0.00 (+0.00%)
At close · Sep 3
Going-concern doubt
— flagged Nov 19, 2024
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt regarding the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 19, 2024
Market Cap
$85,504
Shares
855.04M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$1.35M
+17.3%
FY2023
Net Income
-$2.64M
+23.9%
FY2023
Gross Margin
77.51%
+0.2pp
FY2023
Operating Margin
-153.09%
-13.6pp
FY2023
Diluted EPS
$0.00
+100%
FY2023
Operating Cash Flow
-$1.42M
-83.3%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| $922.01K | $1.35M | $1.15M | $907.36K | $737.96K | $829.74K | |
| $229.78K | $303.3K | $261.2K | $199.23K | $194.38K | $238.52K | |
| $692.23K | $1.05M | $888.64K | $708.13K | $543.57K | $591.22K | |
| — | 77.51% | 77.28% | 78.04% | 73.66% | 71.25% | |
| — | $231.43K | $92.3K | $215.32K | $31.6K | $82.85K | |
| $1.7M | $3.11M | $2.49M | $4.51M | $3.71M | $2.26M | |
| $0 | $4557 | $21.88K | $21.88K | $21.88K | $24.46K | |
| -$1.01M | -$2.06M | -$1.6M | -$3.8M | -$3.17M | -$1.67M | |
| — | -153.09% | -139.46% | -418.83% | -429.11% | -201.1% | |
| -$1.01M | -$2.06M | -$1.58M | -$3.78M | -$3.14M | -$1.64M | |
| $230.88K | $893.16K | $791.07K | $3.31M | $769.59K | $54.81K | |
| -$667.61K | -$576.31K | -$1.86M | -$4.68M | -$705.04K | -$75.71K | |
| -$1.68M | -$2.64M | -$3.47M | -$8.48M | -$3.87M | -$1.74M | |
| — | -195.82% | -301.65% | -934.59% | -524.65% | -210.23% | |
| -$1.68M | -$2.64M | -$3.58M | -$12.25M | -$4.38M | — | |
| USD/shares | $0.00 | $0.00 | -$0.03 | -$0.24 | -$0.20 | — |
| USD/shares | $0.00 | $0.00 | -$0.03 | -$0.24 | -$0.20 | — |
| shares | — | 377.22M | 133.6M | 50.99M | 22.3M | 16.81M |
| shares | — | 377.22M | 133.6M | 50.99M | 22.3M | 16.81M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 28 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.